An observational study in Parkinson Disease, sponsored by Emre Şenocak. Recruiting at 1 site in Turkey. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-03-05.
Sponsored by Emre Şenocak · Observational
This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.
4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.
This study's planned enrollment of 39 is below the median of 96 across 1,057 observational studies indexed under Parkinson Disease.
Browse Parkinson Disease studies →Emre Şenocak is the lead sponsor of 10 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Parkinson Disease
Exclusion Criteria:
There will be only one group in the study. Patients will only be applied to the physiotherapy program recommended by the specialist physician and physiotherapist. It is not possible to apply any additional treatment within the scope of the study.
Other: Rehabilitation
A routine physical therapy program prescribed by a specialist physician and physiotherapist will be applied.
Parkinson Disease Questionnaire-8
It is an 8-item form used to assess the quality of life in Parkinson's disease.
Time frame: 7 days before the Physiotherapy session
Parkinson Disease Questionnaire-8
It is an 8-item form used to assess the quality of life in Parkinson's disease.
Time frame: First day of the physiotherapy session
Parkinson Disease Questionnaire-8
It is an 8-item form used to assess the quality of life in Parkinson's disease.
Time frame: 6 weeks (5 physiotherapy sessions for 6 weeks)
Demographic Data Form
This form was created by researchers and it consist of personal informations such as gender, education, age, body mass index, duration of disease
Time frame: First day of the physiotherapy session
Modified Hoehn & Yahr Scale
It is used to determine the disease stage. It stages the disease between 1 and 5 points. As the stage progresses, disability also increases.
Time frame: First day of the physiotherapy session
Unified Parkinson's Disease Rating Scale (UPDRS)
It can assess Parkinson's disease with its different clinical features, including motor and non-motor. It consists of 4 subsections and 55 items in total. This study will use part III of the UPDRS score (between subsections 3.1 and 3.18)
Time frame: First day of the physiotherapy session
Global Rating of Patient-Perceived Changes (GRP-PC)
GRP-PC will used to assess patient-perceived hand dexterity changes after the routine intervention. The patient will first asked, "Has your hand dexterity changed compared to when you did not receive interventions?". If the answer is no, the person will given a score of 0 (i.e. no change). In the case of positive response, the patient will asked, "How much better or worse is your hand dexterity" and the patient response will scored on the following 14-point Likert scale: +7 (very much better), +6 (much better), +5 (better), +4 (relatively better), +3 (somewhat better), +2 (a little better), +1 (very little better), -1 (very little worse), -2 (a little worse), -3 (somewhat worse), -4 (relatively worse), -5 (worse), -6 (much worse), and -7 (very much worse).
Time frame: 6 weeks (5 physiotherapy sessions for 6 weeks)
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Emre Şenocak